|
市場調査レポート
商品コード
1319150
画像診断の世界市場-2023年~2030年Global Diagnostic Imaging Market - 2023-2030 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
画像診断の世界市場-2023年~2030年 |
出版日: 2023年07月31日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
世界の画像診断市場は、2022年に274億米ドルに達し、2030年には416億米ドルに達すると予測され、予測期間中(2023-2030年)のCAGRは5.5%です。慢性疾患や病的疾患を抱える人々の増加により、前衛的な医療用画像診断の必要性が高まっています。
病態を早期に発見できる診断装置に対するニーズの高まりが、先進的な医療用画像診断装置の市場を拡大しています。技術の向上により、画像を確認した後に必要な報告期間も大幅に短縮されました。画像診断装置の精度と正確さは、技術のアップグレードによってさらに向上しています。
新興国市場の開拓は、予測期間中の世界の医療用画像診断市場の成長を後押しすると期待されています。例えば、2022年4月、ウィプロGEヘルスケアは次世代CTスキャナRevolution Aspireを発表しました。Revolution Aspireは、インドで開発され、エンドツーエンドで製造された先進的な画像ソリューションです。
さらに2023年2月、ヘルスケアイメージングと情報システムのフロンティアである富士フイルムインドは、インド放射線画像学会(IRIA)の第75回全国会議で製品とソリューションのポートフォリオを拡大しました。超音波診断装置Arietta 850 DeepInsightとArietta 650 DeepInsightに加え、MRI装置APERTO Lucent Non-DICOMプリンターAPEOSを発表しました。さらに、サービス&サポートモバイルアプリ「FUJIFILM Connect」も発表しました。
研究費の増加は、今後数年間、世界の画像診断市場に有望な成長機会をもたらすと期待されています。例えば、R&E財団の任務は、研究者を設計し、生涯独創的な調査と教育を支援することにより、放射線医学の未来に資金を提供することです。1984年の設立以来、財団は1,600件以上の助成金を交付してきました。これは、放射線学の調査と患者ケアの向上のための資金として7,000万米ドルに相当します。
訓練を受けた人材の不足は、画像診断業界が直面しているかなりの課題です。画像診断は、専門的なトレーニングと専門知識を必要とする高度に専門的な分野であり、熟練した人材の不足が深刻化しています。
熟練人材不足の主な理由の1つは、画像診断の教育訓練プログラムへの投資不足です。多くの大学や専門学校は画像診断の専門プログラムを提供しておらず、画像診断のためのトレーニングプログラムの数も限られています。
COVID-19のパンデミックと世界各国でのロックダウンにより、あらゆる業種の企業の財務の健全性が影響を受けています。そのため、COVID-19公衆衛生緊急事態の期間中、米国食品医薬品局(FDA)は、スポンサーと研究者を支援し、試験参加者の安全を確保し、適正臨床実施基準(GCP)を遵守し、試験の完全性に対するリスクを最小限に抑えるための一般的な考慮事項を含むガイドラインを発表しました。
ロシア・ウクライナ紛争は、世界の画像診断市場に中程度の影響を及ぼすと考えられます。ウクライナの診療所はロシア軍からの侵攻を受け続けているが、死者数の増加や限られた医療援助に追われています。あらゆる種類のヘルスケア支援が不足しています。また、基本的な材料の輸出入の重要性は、予測期間における世界の画像診断市場の成長に若干の影響を与えると予想されます。
The Global Diagnostic Imaging Market reached US$ 27.4 billion in 2022 and is expected to reach US$ 41.6 billion by 2030, exhibiting a CAGR of 5.5% during the forecast period (2023-2030). The rising number of people with chronic diseases and pathological diseases has raised the need for avant-garde medical imaging procedures.
The rising need for diagnostic devices that can detect conditions earlier has increased the market for progressive medical imaging devices. With the improvement in technology, the reporting period which is needed after the image has been reviewed has also decreased extensively. The precision and accuracy of imaging devices have even improved with the upgrade in technology.
The increasing market developments are expected to boost the global medical imaging market growth in the forecast period. For instance, in April 2022, Wipro GE Healthcare introduced the next-generation Revolution Aspire CT scanner. Revolution Aspire is an advanced imaging solution developed and fabricated end-to-end in India.
Moreover, in February 2023, FUJIFILM India, a frontier in healthcare imaging and information systems, expanded its product and solutions portfolio at the 75th National Conference of the Indian Radiological and Imaging Association (IRIA). The new range possesses ultrasound system Arietta 850 DeepInsight and Arietta 650 DeepInsight along with the new MRI machine APERTO Lucent Non-DICOM printer APEOS. Further, the corporation even presented "FUJIFILM Connect" a service & support mobile application.
The increasing research funding is expected to present the global diagnostic imaging market with prospective growth opportunities in the upcoming years. For instance, the assignment of the R&E Foundation is to fund the future of radiology by designing researchers and helping lifelong ingenious investigation and education. Since the Foundation's beginning in 1984, it has granted more than 1,600 grants. That's $70 million in funding for radiology investigation and enhancing patient care.
The shortage of trained personnel is a considerable challenge facing the diagnostic imaging industry. Diagnostic imaging is a highly specialized field requiring specialized training and expertise, and there is a growing shortage of skilled personnel.
One of the primary reasons for the shortage of skilled personnel is the lack of investment in education and training programs for diagnostic imaging. Many universities and colleges do not offer specialized programs in diagnostic imaging, and there is a limited number of training programs available for diagnostic imaging.
The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.
The Russia-Ukraine conflict is thought to hold a moderate influence on the global diagnostic imaging market, as there is a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all types of healthcare assistance. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global diagnostic imaging market growth in the forecast period.
The global diagnostic imaging market is segmented based on product type, disease type, end-user, and region.
The tomography type of diagnostic imaging is expected to hold around 37.8% of the global market share owing to the increasing product introductions into the market. For instance, in May 2023, Royal Philips, a multinational leader in health technology, launched the Philips CT 3500, a new high-throughput CT system targeting the requirements of everyday radiology and high-volume screening schedules.
Powered by AI, the Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing characteristics that aid to provide the consistency, rate, and first-time-right image grade ought for assured diagnoses by clinicians and improved recovery on investment in the highly selective, high-volume care environments.
Moreover, in March 2022, at the 74th National Conference, IRIA 2022, Bengaluru, Siemens Healthineers introduced its latest product MAGNETOM Free. Star and NAEOTOM Alpha in MRI and CT pipeline. These product takeoffs supported the corporation broaden its consumer ground by delivering state-of-the-art medical imaging technology.
Owing to the increasing cases of chronic diseases in this region, Europe is estimated to dominate the global market holding around 28.6% of the market by 2030. For instnace, according to the European Heart Network AISBL, annually cardiovascular conditions (CVD) causes 3.9 million casualties in Europe and more than 1.8 million deaths in the European Union (EU), CVD makes up for over 45% of all deaths in Europe and 37% of all deaths in the EU.
CVD is the primary reason for death in males in all whereas 12 nations of Europe and is the primary reason for death in females in all but two countries. Death rates from both ischaemic heart disease (IHD) and stroke are typically more increased in Central and Eastern Europe compared to Northern, Southern, and Western Europe.
The major global players in the diagnostic imaging market include: GE Healthcare, Siemens Healthcare, Carestream Health Inc., Hitachi Medical Corporation, Canon Toshiba Medical Systems Corporation, Hologic Corporation, Philips Healthcare, Fujifilm Holdings Corporation, and Shimadzu Corporation, among others.
The global diagnostic imaging market report would provide approximately 53 tables, 54 figures, and 195 Pages.
Australia
LIST NOT EXHAUSTIVE